Open AccessLung cancer, arthritis and gout: reports from ASCO and EULAR
Author(s) -
Lyon Sue
Publication year - 2009
Publication title -
future prescriber
Language(s) - English
Resource type - Journals
eISSN - 1931-2261
pISSN - 1468-9871
DOI - 10.1002/fps.53
Subject(s) - medicine , lung cancer , gout , cancer , clinical oncology , alternative medicine , disease , arthritis , intensive care medicine , oncology , physical therapy , family medicine , pathology
The second most common cancer diagnosed in the UK, lung cancer, is also the most deadly. Over twothirds of patients present with advanced disease, and at present only 7% survive for at least five years after diagnosis. 1 New hope is offered by studies presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO), held on 28 May–2 June in Orlando, USA Copyright © 2009 John Wiley & Sons, Ltd.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom